Opna Bio logo
Opna Bio logo

Opna Bio

opnabio.com
opnabio.com • 51-200 employees • Founded 2020 • Likely startup • New
51-200 employees • Founded 2020 • Likely startup • New
Actively hiring
Oncology Therapeutics
Biologics & Biosimilars
Health Care
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
51-200
employees, estimated range
Backers
2
Longitude Capital, Menlo Ventures
Momentum
0/100
no fresh signals
Registers and programsofficial lists and records that name the company
Legal entity Opna Bio SA its site
Backed byfrom the funds' portfolios and accelerator catalogs
Longitude Capital fund Menlo Ventures fund
Similar startupsby what they do, their industry and backers
VeradermicsConvertible Note $30M · 4 mo ago • Founded 2020
Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company.
cAMPfield TherapeuticsFounded 2026 • 3 roles
CAMPfield Therapeutics is a clinical-stage biopharmaceutical company developing prifemilast, a once-daily oral PDE4B-selective inhibitor…
LabGenius51-200 employees
LabGenius Therapeutics is pioneering a closed-loop platform that combines AI, robotic automation, and synthetic biology to accelerate the…
Alentis TherapeuticsFounded 2019 • 51-200 employees
THE CLAUDIN-1 COMPANY Treat cancer and reverse fibrosis We are a clinical-stage biotech company with a mission to treat cancer and reverse…
Immunai13 roles
We partner with top biopharmaceutical companies and research institutions to discover and advance novel therapeutics.
Tribune TherapeuticsFounded 2020
Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a…

Overview

Opna Bio is a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics. The company’s lead program is OPN-6602, a dual EP300/CBP inhibitor, currently in a Phase 1 clinical trial in patients with multiple myeloma.